Presentation is loading. Please wait.

Presentation is loading. Please wait.

1 Monsanto Company Confidential ICABR Conference Kelly Fleming 20 June, 2013.

Similar presentations


Presentation on theme: "1 Monsanto Company Confidential ICABR Conference Kelly Fleming 20 June, 2013."— Presentation transcript:

1 1 Monsanto Company Confidential ICABR Conference Kelly Fleming 20 June, 2013

2 2 Monsanto Company Confidential Notes Certain statements contained in this presentation are “forward-looking statements,” such as statements concerning the company’s anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company’s actual performance and results may differ materially from those described or implied by such forward- looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company’s exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company’s research and development activities; the outcomes of major lawsuits; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company’s estimates related to distribution inventory levels; the company’s ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company’s facilities; and other risks and factors detailed in the company’s most recent reports on Forms 10-Q and 10-K. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this presentation. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results. Monsanto Imagine and the Vine Design, Channel, Channel Bio, D&PL, Deltapine, DEKALB, DEKALB and Winged Ear Design, When Performance Counts, Asgrow, Asgrow and Design, Acceleron, Acceleron and Design, Apex, BioDirect, Biotech Yield Endorsement, BYE, Bollgard, Bollgard II, Bollgard and Design, Bollgard II and Design, Corn States Triangle Design, Cotton States, Cotton States and Design, Discovering, Delivering, Yielding., EarthMap Solutions and Design, Growing Yield Sustainably, Our Science Your Success and Design, Processor Preferred, Produce More, Conserve More, Roundup, Roundup PowerMax, Roundup Pro, Roundup ProMax, Roundup Ready, Roundup Ready 2 Yield, Roundup Powerful Performance and Design, Roundup Ready Rate and Design, Roundup Rewards, Roundup Technology, Roundup WeatherMax, SmartStax, SmartStax and Design, Vistive, Vistive and Design, YieldGard, YieldGard Rootworm and Design, YieldGard Corn Borer and Design, YieldGard Plus and Design, YieldGard VT, YieldGard VT and Design, YieldGard VT Triple, YieldGard VT Rootworm/RR2, VT Double PRO, VT Triple PRO, Genuity, Genuity and Design and Genuity Icons, Seminis, Seminis Vegetable Seeds and Design and De Ruiter are trademarks and service marks owned by Monsanto Company and its wholly owned subsidiaries. All other trademarks are the property of their respective owners. © 2010 Monsanto Company. All Rights Reserved.

3 3 Monsanto Company Confidential It All Adds up to a Doubling in Global Grain Demand Source: IHS Global Insights, Agriculture Division TODAY GLOBAL GRAIN DEMAND (M MT) +102% +40% +76% +28% +125%

4 4 Monsanto Company Confidential Our R&D Engine is Evolving to Deliver Tomorrow’s Products as Systems Applied On-Farm Genes, Germplasm, Chemistries R&D Engine 2 Seed + crop management Diseases, Pests, and Weeds Crop Residues Seed Selection Plant Population Nutrients Products 3 Product concepts based on farmers’ needs 1 4

5 5 Monsanto Company Confidential Biologicals Complement our Systems Approach to Increasing Yield Reducing Agricultural Inputs with More Sustainable Solutions Green / Sustainable Healthier Dietary Habits Regulatory Pressure on Some Chemistry Emerging Trends 1 BreedingBiotechnologyBiologicalsChemistryAgronomics Highest yielding genetics for target environment Complementary agronomic and yield enhancing traits Plant Health Extended Disease Protection Mid Season Insect control Bio-Nutrients Traits & Germplasm provide platform for Ag chemistry Products Farm management practices and optimizing genetic placement on the farm 5

6 6 Monsanto Company Confidential What are Biologicals? Sustainable/ Green Trends Healthier Dietary Habits Scientific Advances Improved Plant Testing 1 6 Definition Foliar or seed treatment products which are: Based on or containing a living organism May be used to complement or replace Ag chemistry products May have a shorter, cheaper regulatory cycle than Ag chem products Key Segments Foliar or seed treatment products which are: Microbials Pesticides Plant Health/Inoculants BioDirect™ Technology— RNA Plant Growth Regulators Pheromones Beneficial Insects Driven By 2 3

7 7 Monsanto Company Confidential Global Ag Biologicals Industry Primarily Supports Fruit and Vegetable Crops Row Crops > 15% of Biologicals Focused on Row Crops Vegetables > Trees, Vines, Orchard, Fruits > 7

8 8 Monsanto Company Confidential Biologicals Research Focus TECHNOLOGY ™ Weed Management Insect Management Virus Control Bee Health Microbials Pest ControlPlant Vigor & Yield Seed Treatment Foliar Applications IFS Delivery Methods + For Monsanto, Biologicals = BioDirect™ Technology+ Microbials Disease Control

9 9 Monsanto Company Confidential NEXT INFLECTION POINT New BioDirect™ Technology is Next Step in Evolution of Technologies for Solving Farmers’ Challenges Evolution: AG Platforms Driving YieldNext Inflection Point Monsanto’s leading genomics and agronomics systems capability are key catalysts: data and insight enables multiple, complementary R&D platforms NEW Genomics 1980s1990s2000s2010s BioDirect TM Monsanto’s Biological Ag Solutions Technology Creating potential breakthrough AG biological products with BioDirect TM technology NEW AG Biologicals Integrated Farming Systems℠ (IFS) Advanced Breeding AG Biotechnology Synthetic Agricultural Chemicals

10 10 Monsanto Company Confidential BioDirect ™ is Based on New Applications of RNAi Technology RNAi is A Natural Mechanism to Control the Expression of a Gene

11 11 Monsanto Company Confidential Early Testing Indicates BioDirect™ Technology Has Potential To Be Step Change In Weed Control Non-transgenic weed control topical technology designed to complement glyphosate chemistry to target glyphosate-resistant weeds and provide broader spectrum of control Complementary to Monsanto’s other weed control platforms BioDirect TM Technology Glyphosate-Resistant Weed Control Targets Resistant Weeds Glyphosate-Resistant (GR) Palmer Pigweed Control Field Trials Tunica, Mississippi – 2012 GR Palmer pigweed sprayed with glyphosate alone GR Palmer pigweed sprayed with BioDirect™ Technology + glyphosate Glyphosate-Resistant Waterhemp Lab Trials – 2012 Untreated Check Glyphosate Only Glyphosate + BioDirectTM Technology

12 12 Monsanto Company Confidential Initial Testing Indicates BioDirect™ Technology Could Provide Significant New Source of Protection Against Insect Pests * Photo of plants depict plants grown and treated in lab environment Non-transgenic insect control topical technology designed as a new source to control insects for potential opportunity across a spectrum of crops Leverages Monsanto’s core capability in genomics, using genome sequences to identify more precise, effective tools for pest control BioDirect TM Insect Control Technology Colorado Potato Beetle Lab Trials* Monsanto Research – 2012 Untreated plants Plants protected with BioDirect™ Technology Mexican Bean Beetle Lab Trials* Lab Trials – 2012 Untreated plants Plants protected with BioDirect™ Technology

13 13 Monsanto Company Confidential Initial Testing Indicates BioDirect™ Technology Could Reduce The Symptoms Of Viruses * Photo of plants depict plants grown and treated in lab environment Non-transgenic virus control topical technology designed as a new tool to potentially reduce the impacts of viruses Leverages Monsanto’s core capability in genomics, using genome sequences to identify more precise, effective tools for virus control Virus Control in Pepper Lab Trials* Monsanto Research – 2012 Untreated plants Plants protected with BioDirect™ Technology Virus Control in Tomato Lab Trials* Lab Trials – 2012 Untreated plants Plants protected with BioDirect™ Technology BioDirect TM Virus Control Technology

14 14 Monsanto Company Confidential Bee Health Focus Establish complete and annotated genomics database of phoretic and brood mites Viral sequencing used to select targets Substantial and reproducible Varroa gene silencing by feeding Analytical methods Virus and Varroa field data assessment developed, field trial completed Delivery to Varroa by feeding bees shown Formulations and application methods are being developed Field study with Dr. Jamie Ellis (UF) initiated Varroa Genomics, Viral Sequencing BioDirect Technology Proof of Concept Field Testing Analytics Varroa Delivery Methods

15 15 Monsanto Company Confidential BioDirect™ Technology We’re just beginning to explore this technology, but believe potential pest control products (weed, insect, and virus) will expand farmers’ choices. BioDirect ™ is the first AG biological technology we have in discovery. BioDirect™ technology uses molecules found in nature and are selected to be effective and specific for their intended target. BioDirect™ technology is expected to further support farmer and consumer demand for sustainable agricultural practices. Monsanto is investing in a new R&D platform called Agricultural Biologicals.

16 16 Monsanto Company Confidential Microbials Offer Additional Biological Solutions for Agriculture New Technologies Are Enabling Discoveries to Expand Agricultural Impact of Microbial Biologicals Microbial Products Are Emerging in Row Crops  Genomic analysis of microbe-plant communities  Enhanced screening and analytics to discover high performance microbial agents  High-resolution Field Testing  Status: Building increased microbial field testing capacity for potential in-licensing opportunities and internal discovery research via Agradis acquisition

17 17 Monsanto Company Confidential Thank you


Download ppt "1 Monsanto Company Confidential ICABR Conference Kelly Fleming 20 June, 2013."

Similar presentations


Ads by Google